Astec Lifesciences logo

Astec Lifesciences

ASTEC NSE

Key Fundamentals

MicrocapPesticides & AgrochemicalsChemicals
Market Cap
₹1,571 Cr
Volatility
Moderate
P/E Ratio
-23.8
EBITDA
₹0.50 Cr
Return on Equity
-20.69%
Debt to Equity
1.15
Book Value
₹175.29
EPS
₹0
52W High
₹941.75
52W Low
₹513.4

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

7
  • Stock is trading at 3.99 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -4.18% over past five years.
  • Company has a low return on equity of -26.0% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.3.21 Cr.
  • Company has high debtors of 202 days.

Growth Rate

Revenue Growth
17.14% higher than 3Y
Net Income Growth
-39.94% lower than 3Y
Cash Flow Change
-861% higher than 3Y
ROE
-63.9% lower than 3Y
ROCE
-48.02% lower than 3Y
EBITDA Margin (Avg.)
-101% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
143
111
51
154
69
99
94
120
91
74
125
159
84
Expenses
140
114
69
141
116
118
100
114
102
80
121
149
84
Operating Profit
3
-3
-18
13
-46
-20
-6
6
-11
-7
4
9
-1
OPM %
2.2%
-3.1%
-36%
8%
-67%
-20%
-6%
4.6%
-12%
-9%
3.2%
6%
-0.8%
Other Income
2
1
1
2
1
2
2
1
1
1
-1
3
1
Interest
6
6
6
7
7
9
10
10
11
8
7
8
8
Depreciation
9
9
9
9
9
11
11
12
11
10
11
12
11
PBT
-11
-18
-32
-1
-62
-39
-25
-16
-33
-24
-16
-8
-19
Tax %
-26%
-24%
-24%
4%
-36%
0%
61%
3%
0%
0%
0%
-2%
0%
Net Profit
-8
-13
-24
-1
-40
-39
-40
-16
-33
-24
-16
-8
-19
EPS in Rs
-3.66
-6
-10.86
-0.43
-17.73
-17.21
-18.03
-7.18
-14.75
-10.96
-7.05
-3.48
-8.4
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
267
233
299
368
431
523
555
677
628
458
381
448
441
Expenses
213
201
236
299
354
437
443
522
551
464
448
453
435
Operating Profit
54
32
63
69
76
85
112
154
77
-6
-66
-4
6
OPM %
20%
14%
21%
19%
18%
16%
20%
23%
12%
-1.3%
-17%
-1%
1.3%
Other Income
-16
4
-8
12
11
12
8
10
13
6
6
3
3
Interest
13
13
12
11
12
13
5
9
21
25
37
35
31
Depreciation
13
10
14
15
19
23
26
34
34
36
44
45
44
PBT
13
12
29
56
56
61
89
121
35
-62
-141
-81
-67
Tax %
-17%
59%
33%
37%
36%
23%
27%
26%
27%
-24%
-4%
0%
—
Net Profit
15
5
19
35
36
48
65
90
26
-47
-135
-81
-67
EPS in Rs
6.66
2.24
8.57
15.65
16.03
21.21
29.04
40.12
11.41
-20.95
-60.16
-36.32
-29.89
Div. Payout %
16%
0%
15%
8%
8%
6%
5%
3%
12%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
19
19
20
20
20
20
20
20
20
20
20
22
Reserves
116
99
119
150
183
227
290
377
400
350
215
368
Borrowings
93
127
127
125
176
99
187
279
341
494
555
449
Other Liabilities
133
85
69
119
83
226
181
221
219
112
92
102
Total Liabilities
362
330
334
413
461
572
678
897
979
975
881
942
Fixed Assets
133
95
103
115
167
194
213
340
318
386
499
459
CWIP
12
20
8
42
19
24
116
23
127
165
21
20
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
216
215
223
256
275
354
349
534
534
424
361
463
Total Assets
362
330
334
413
461
572
678
897
979
975
881
942
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
7
-13
19
65
15
168
-8
24
75
10
-8
-81
Investing
-19
-17
-18
-49
-52
-74
-73
-104
-113
-135
-15
-4
Financing
12
31
-1
-18
37
-95
81
80
38
125
24
94
Net Cash Flow
0
2
1
-3
0
0
0
0
0
0
0
9
Free Cash Flow
-13
-39
-1
15
-37
123
-111
-80
-42
-125
-24
-86
CFO/OP
19
-24
41
116
41
219
13
34
104
-211
20
1,796
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
142
126
135
122
103
112
123
148
90
135
141
202
Inventory Days
147
177
133
122
121
131
113
176
268
224
196
169
Days Payable
179
169
116
155
83
218
137
179
161
102
100
107
Cash Conversion Cycle
109
134
152
89
142
25
100
145
197
256
237
263
Working Capital Days
19
-28
1
-8
-2
8
4
12
-17
-1
-26
-56
ROCE %
20%
12%
20%
22%
20%
20%
22%
22%
8%
-4%
-13%
-5%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Astec Lifesciences insights

64 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

FIIs0.01%Promot.71.96%DIIs3.33%Others4.22%Public20.48%As ofJun 2026

Documents

Frequently Asked Questions about Astec Lifesciences

What does Astec Lifesciences Ltd do?
The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries. Astec also has undertaken a number of custom synthesis projects, for its clients...
Where is Astec Lifesciences Ltd (ASTEC) listed?
Astec Lifesciences Ltd trades as ASTEC on the NSE and under code 533138 on the BSE.
Which sector does Astec Lifesciences Ltd belong to?
Astec Lifesciences Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the market capitalisation of Astec Lifesciences Ltd?
Astec Lifesciences Ltd has a market capitalisation of ₹1,571 Cr, which places it in the Small Cap band.
What is the PE ratio of Astec Lifesciences Ltd?
Astec Lifesciences Ltd trades at a PE ratio of -23.80, on earnings per share of ₹0, against a book value of ₹175.29 per share.
What is the 52-week high and low of Astec Lifesciences Ltd?
Over the last 52 weeks Astec Lifesciences Ltd has traded between ₹513.4 and ₹941.75.
Does Astec Lifesciences Ltd pay dividends?
Astec Lifesciences Ltd has a dividend yield of 0.21%.
What is the Return on Equity (ROE) of Astec Lifesciences Ltd?
Astec Lifesciences Ltd reported a return on equity of -20.69%. Its debt-to-equity ratio is 1.15.

Company Information

The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries. Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).[1] [2] [3]

Website godrejastec.com
CEO Mr. Burjis Nadir Godrej
Employees 555
Listed 2009-11-25
Face Value ₹ 10
Issued Size 2,24,13,383

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ASTEC.md for Astec Lifesciences Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List